About 12 results found for searched term "ERK1/2 inhibitor 2" (0.128 seconds)
Cat.No. | Name | Target |
---|---|---|
M10741 | ERK1/2 inhibitor 2 | ERK |
ERK1/2 inhibitor 2 (Example 1) is a potent dual ERK1/2 inhibitor. ERK1/2 inhibitor 2 has anti-cancer activity. | ||
M5345 | Ulixertinib (BVD-523) | ERK |
VRT752271; BVD523, Ulixertinib | ||
VRT752271 (BVD-523, Ulixertinib) is an orally available, highly selective, ATP-competitive, reversible ERK1/2 inhibitor with an IC50 of <0.3 nM for ERK2 inhibition. | ||
M9803 | MK-8353 | ERK |
SCH900353 | ||
MK-8353 (SCH900353) is an orally bioavailable, selective, and potent ERK1/2 inhibitor, with IC50 values of 23.0 nM and 8.8 nM, respectively. | ||
M11529 | Temuterkib | ERK |
LY3214996 | ||
Temuterkib (LY3214996) is a selective, novel erK1/2 inhibitor with an IC50 of 5 nM against ERK1 and ERK2. It can effectively inhibit intracellular P-RSK1 in cancer cell lines with BRAF and RAS mutations. Temuterkib has strong antitumor activity in cancer models with altered MAPK pathways. | ||
M14152 | ERK1/2 inhibitor 1 | ERK |
ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively. | ||
M42119 | ERK1/2 inhibitor 9 | ERK |
ERK1/2 inhibitor 9 (Probe 1) is a covalent ERK1/2 inhibitor. | ||
M49692 | ERK1/2 inhibitor 7 | ERK |
ERK1/2 inhibitor 7 is a potent ERK inhibitor with an IC50 of 0.94 nM for ERK2. | ||
M49701 | ERK1/2 inhibitor 3 | ERK |
ERK1/2 inhibitor 3 is a potent inhibitor of ERK1/2. | ||
M49702 | ERK1/2 inhibitor 4 | ERK |
ERK1/2 inhibitor 5 is a potent inhibitor of ERK1/2. | ||
M49703 | ERK1/2 inhibitor 5 | ERK |
ERK1/2 inhibitor 5 is a potent inhibitor of ERK1/2. | ||
M49704 | ERK1/2 inhibitor 6 | ERK |
ERK1/2 inhibitor 6 is a potent inhibitor of ERK1/2. | ||
M49705 | ERK1/2 inhibitor 8 | ERK |
ERK1/2 inhibitor 8 is a potent ERK inhibitor with an IC50 of 0.48 nM for ERK2. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.